Clinical Trial Update: SGLT-2 Inhibitors in Prevention of Post-procedural Renal and Cardiovascular Complications aFter PCI Among Patients With Diabetes Mellitus and Coronary Artery Disease: a Prospective, Randomized, Pilot Study (SAFE-PCI) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial assessing whether SGLT-2 inhibitors can prevent post-procedural renal and cardiovascular complications after PCI in patients with type …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Kidney Injury
• Type 2 Diabetes Mellitus

Snippet

Sponsor: University of Sao Paulo General Hospital | Conditions: Diabetes Mellitus, Type 2, Coronary Artery Disease | Phase 4 | Status: UNKNOWN